Use a Checklist to Help Patients Safely Take DOACs

October 2015

We're getting questions about how to monitor patients on direct oral anticoagulants...apixaban, dabigatran, edoxaban, and rivaroxaban.

We know these "DOACs" (Direct Oral AntiCoagulants) don't have good lab tests to assess efficacy and bleeding risk...like INR with warfarin.

But they still need clinical monitoring to ensure appropriate use.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote